BiotechTube
Home/Medmain/Masayuki Tsuneki
MT

Masayuki Tsuneki

Board of Director

Medmain

Therapeutic Areas

Oncology

Medmain Pipeline

DrugIndicationPhase
PidPort AI AnalysisPathological screening of tissue and cellsCommercial
Ki-67 Labeling Index AIAssessment in immunohistochemical specimensResearch/Development

Leadership Team at Medmain

OI
Osamu Iizuka
CEO
AM
Atsushi Murakami
Board of Director
View full Medmain profile